36 related articles for article (PubMed ID: 3529053)
1. Do glucagonomas always produce glucagon?
Wewer Albrechtsen NJ; Challis BG; Damjanov I; Holst JJ
Bosn J Basic Med Sci; 2016 Feb; 16(1):1-7. PubMed ID: 26773171
[TBL] [Abstract][Full Text] [Related]
2. Effect of monoclonal antibodies to enteroglucagon on ileal adaptation after proximal small bowel resection.
Gregor M; Menge H; Stössel R; Riecken EO
Gut; 1987; 28 Suppl(Suppl):9-14. PubMed ID: 3692320
[TBL] [Abstract][Full Text] [Related]
3. Striking the Balance: GLP-1/Glucagon Co-Agonism as a Treatment Strategy for Obesity.
Hope DCD; Vincent ML; Tan TMM
Front Endocrinol (Lausanne); 2021; 12():735019. PubMed ID: 34566894
[TBL] [Abstract][Full Text] [Related]
4. Purification and sequence of rat oxyntomodulin.
Collie NL; Walsh JH; Wong HC; Shively JE; Davis MT; Lee TD; Reeve JR
Proc Natl Acad Sci U S A; 1994 Sep; 91(20):9362-6. PubMed ID: 7937770
[TBL] [Abstract][Full Text] [Related]
5. Development of an oxyntomodulin/glicentin C-terminal radioimmunoassay using a "thiol-maleoyl" coupling method for preparing the immunogen.
Blache P; Kervran A; Martinez J; Bataille D
Anal Biochem; 1988 Aug; 173(1):151-9. PubMed ID: 3189794
[TBL] [Abstract][Full Text] [Related]
6. Distribution of oxyntomodulin and glucagon in the gastrointestinal tract and the plasma of the rat.
Kervran A; Blache P; Bataille D
Endocrinology; 1987 Aug; 121(2):704-13. PubMed ID: 3595539
[TBL] [Abstract][Full Text] [Related]
7. Isolation of glucagon-37 (bioactive enteroglucagon/oxyntomodulin) from porcine jejuno-ileum. Characterization of the peptide.
Bataille D; Tatemoto K; Gespach C; Jörnvall H; Rosselin G; Mutt V
FEBS Lett; 1982 Sep; 146(1):79-86. PubMed ID: 7140977
[TBL] [Abstract][Full Text] [Related]
8. The biological significance of "enteroglucagon." Present status.
Bataille D; Jarrousse C; Kervran A; Depigny C; Dubrasquet M
Peptides; 1986; 7 Suppl 1():37-42. PubMed ID: 3529053
[TBL] [Abstract][Full Text] [Related]
9. Enteroglucagon.
Holst JJ
Annu Rev Physiol; 1997; 59():257-71. PubMed ID: 9074764
[TBL] [Abstract][Full Text] [Related]
10. The Enigmatic N-Terminal Domain of Proglucagon; A Historical Perspective.
Conlon JM
Front Endocrinol (Lausanne); 2021; 12():683089. PubMed ID: 34177808
[TBL] [Abstract][Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
